Martingale Asset Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-39,420
| Closed | -$124K | – | 812 |
|
|
2023
Q1 | $124K | Buy |
39,420
+6,724
| +21% | +$21.1K | ﹤0.01% | 800 |
|
|
2022
Q4 | $193K | Buy |
32,696
+1,500
| +5% | +$8.85K | ﹤0.01% | 796 |
|
|
2022
Q3 | $274K | Buy |
31,196
+1,767
| +6% | +$15.5K | 0.01% | 725 |
|
|
2022
Q2 | $222K | Buy |
+29,429
| New | +$222K | ﹤0.01% | 793 |
|
|
2022
Q1 | – | Sell |
-16,109
| Closed | -$519K | – | 813 |
|
|
2021
Q4 | $519K | Buy |
+16,109
| New | +$519K | 0.01% | 637 |
|